Pfizer continued to spend on research through the next several decades, although they often acquired outsourced licenses for distribution of products developed by other companies. In the late 20th century the company renewed its focus on the development of new drugs. In the 1980's they generated several drugs that would sell heavily in the next decade. By the 1990's the company was spending $1.2 billion on research of new drugs each year [12].